{
    "code": "02023000",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02023000",
    "time": "2020-03-20 03:09:37",
    "許可證字號": "衛署藥輸字第023000號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "109\/09\/21",
    "發證日期": "89\/09\/21",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202300007",
    "中文品名": "帕特捷　筆型注射液",
    "英文品名": "APO-GO PEN 10MG\/ML",
    "適應症": "改善巴金森氏病後期藥效波動現象，如：LEVODOPA或其他DOPAMINE作用劑（BROMOCRIPTINE、LISURIDE、PERGOLIDE）製劑無法適當地控制病患之運動不能、暫時性肌麻痺等症狀。",
    "劑型": "270注射劑",
    "包裝": "5pens盒裝 3ml筆裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "APOMORPHINE HCL",
    "限制項目": "02輸　入",
    "申請商名稱": "1407301100  臺灣美強股份有限公司",
    "申請商地址": "台北市中山區南京東路二段66號4樓",
    "主製造廠": [
        {
            "製造廠名稱": "FGB0269100  CP PHARMACEUTICALS LIMITED",
            "製造廠廠址": "ASH ROAD NORTH WREXHAM INDUSTRIAL ESTATE WREXHAM, LL13 9UF UNITED KINGDOM",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED KINGDOM",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "6131180602  台灣美強股份有限公司",
            "製造廠廠址": "新北市深坑區北深路3段155巷5號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "二級包裝廠(委託貼標及置入仿單)"
        },
        {
            "製造廠名稱": "FFR0159100  LABORATOIRE AGUETTANT",
            "製造廠廠址": "1 RUE ALEXANDER FLEMING, 69007 LYON, FRANCE",
            "製造廠公司地址": "",
            "製造廠國別": "FRANCE",
            "製程": "包裝"
        },
        {
            "製造廠名稱": "FGB0291000  BRITANNIA PHARMACEUTICALS LTD.",
            "製造廠廠址": "200 Longwater Avenue, Reading Berkshire,RG2 6GP ,UK",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED KINGDOM",
            "製程": "許可證持有者"
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "5620000110",
            "成分名稱": "APOMORPHINE HCL",
            "含量描述": "",
            "含量": "10.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "15.7cm注射筆，玻璃注射水匣內有注射液。",
        "特殊劑型": "",
        "顏色": "澄清無色溶液",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "APO-go Pen_注射筆外觀、標籤-109-02-15.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023000&Seq=002&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "APO-go Pen_中文仿單 使用說明_v7_202002-109-02-15.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023000&Seq=011&Type=9"
        },
        {
            "title": "201612_中文仿單 _使用說明-106-01-16.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023000&Seq=009&Type=9"
        },
        {
            "title": "APO-go Pen_外盒-109-02-15.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023000&Seq=012&Type=8"
        },
        {
            "title": "APO-go Pen_中文標籤_v5-109-02-15.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023000&Seq=011&Type=8"
        }
    ]
}